 |
 |
 |
| 1. |
Emori M, Tamakawa M, Kaya M, Takada K, Murase K, Fujita C, Sato S, Takahashi R, Hatanaka KC, Sugita S, Hirano H, Yamashita T, Hasegawa T. A typical presentation of primary pulmonary epithelioid sarcoma misdiagnosed as non-small cell lung cancer. Pathol Int. 67: 222-224, 2017. |
| 2. |
Kawano Y, Miyanishi K, Takahashi S, Kubo T, Ishikawa K, Sugita S, Takada K, Kobune M, Hasegawa T, Kato J. Hepatitis C virus reactivation due to antiemetic steroid therapy during treatment of hepatocellular carcinoma. J Infect Chemother. 23: 323-325, 2017. |
| 3. |
Sugita S, Arai Y, Aoyama T, Asanuma H, Mukai W, Hama N, Emori M, Shibata T, Hasegawa T. NUTM2A-CIC fusion small round cell sarcoma: A genetically distinct variant of CIC-rearranged sarcoma. Hum Pathol. 65: 225-230, 2017. |
| 4. |
Sugita S, Hasegawa T. Practical use and utility of fluorescence in situ hybridization in the pathological diagnosis of soft tissue and bone tumors. Journal of Ortho Sci. 22: 601-613, 2017. |
| 5. |
Kubo T, Sugita S, Wada R, Kikuchi N, Iwasaki M, Ito Y, Sugawara T, Fujita H, Emori M, Tanaka R, Hirano H, Saito T, Hasegawa T. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma. Diagnostic Pathology. 12: 26, 2017. |
| 6. |
Kikuchi N, Sugita S, Nakanish K, Sugawara T, Segawa K, Ito Y, Kubo T, Fujita H, Hirano H, Tanaka R, Saito T, Hasegawa T. Ovarian high-grade endometrioid stromal sarcoma with YWHAE and NUTM2B rearrangements. Pathol Int. 67: 327-329, 2017. |
| 7. |
Sugita S, Aoyama T, Ito Y, Asanuma H, Sugawara T, Segawa K, Ito Y, Kikuchi N, Tsujiwaki M, Fujita H, Ono Y, Hasegawa T. Diagnostic utility of automated SureFISH (Dako Omnis) in the diagnosis of musculoskeletal translocation-related sarcomas. Pathol Int 67: 510-513, 2017. |
| 8. |
Yamaguchi M, Hirai S, Tanaka Y, Sumi T, Miyajima M, Mishina T, Yamada G, Otsuka M, Hasegawa T, Kojima T, Niki T, Watanabe A, Takahashi H, Sakuma Y. Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis. Lab Invest 97: 232-242, 2017. |
| 9. |
Hasegawa T, Someya M, Hori M, Matsumoto Y, Nakata K, Nojima M, Kitagawa M, Tsuchiya T, Masumori N, Hasegawa T, Sakata KI. Expression of Ku70 predicts results of radiotherapy in prostate cancer. Strahlenther Onkol 193: 29-37, 2017. |
| 10. |
Hori M, Someya M, Matsumoto Y, Nakata K, Kitagawa M, Hasegawa T, Tsuchiya T, Fukushima Y, Gocho T, Sato Y, Ohnuma H, Kato J, Sugita S, Hasegawa T, Sakata KI. Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy. Med Mol Morphol 50: 25-33, 2017. |
| 11. |
Ueda A, Takasawa A, Akimoto T, Takasawa K, Aoyama T, Ino Y, Nojima M, Ono Y, Murata M, Osanai M, Hasegawa T, Saito T, Sawada N. Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix. PLoS One 31: e0184123, 2017. |
| 12. |
Yamaguchi M, Hirai S, Sumi T, Tanaka Y, Tada M, Nishii Y, Hasegawa T, Uchida H, Yamada G, Watanabe A, Takahashi H, Sakuma Y. Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma. Biochem Biophys Res Commun 487: 613-618, 2017. |
| 13. |
Yasuda K, Hirohashi Y, Mariya T, Murai A, Tabuchi Y, Kuroda T, Kusumoto H, Takaya A, Yamamoto E, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Tamura Y, Hirano H, Hasegawa T, Saito T, Sato N, Torigoe T. Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27. Oncotarget 8: 31540-31553, 2017. |
| 14. |
Kubo T, Hirohashi Y, Matsuo K, Sonoda T, Sakamoto H, Furumura K, Tsukahara T, Kanaseki T, Nakatsugawa M, Hirano H, Furuhata T, Takemasa I, Hasegawa T, Torigoe T. Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative "Adaptive Immune Escape" Phenomenon. Anticancer Res 37: 1289-1295, 2017. |
| 15. |
Horibe R, Hirohashi Y, Asano T, Mariya T, Suzuki T, Takaya A, Saijo H, Shionoya Y, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Watanabe K, Atsuyama E, Toji S, Hirano H, Hasegawa T, Takahashi H, Sato N, Torigoe T. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy. PLoS One 12: e0171460, 2017. |
| 16. |
Kanno S, Nosho K, Ishigami K, Yamamoto I, Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S, Tanuma T, Maguchi H, Hasegawa T, Kimura Y, Takemasa I, Shinomura Y, Nakase H. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer. Carcinogenesis 38: 425-431, 2017. |
| 17. |
Tabata S, Murata M, Takasawa A, Fukuda A, Ogasawara J, Koseki T, Nakano K, Segawa K, Morita R, Hasegawa T, Sawada N. Cytological findings of langerhans cell sarcoma in a case of quintuple cancer. Diagn Cytopathol 45: 441-445, 2017. |
| 18. |
Yamamoto I, Nosho K, Kanno S, Igarashi H, Kurihara H, Ishigami K, Ishiguro K, Mitsuhashi K, Maruyama R, Koide H, Okuda H, Hasegawa T, Sukawa Y, Okita K, Takemasa I, Yamamoto H, Shinomura Y, Nakase H. EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics. Oncotarget 8: 17810-17818, 2017. |
| 19. |
Maeda T, Fujita Y, Imafuku K, Nakazato S, Hata H, Nomura T, Mitsuhashi T, Anan T, Hasegawa T, Hamaoka S, Shimizu H. Subcutaneous Nodule on the Right Palm of a Young Boy: A Quiz. Acta Derm Venereol 97: 1150-1151, 2017. |
| 20. |
Niinuma T, Kai M, Kitajima H, Yamamoto E, Harada T, Maruyama R, Nobuoka T, Nishida T, Kanda T, Hasegawa T, Tokino T, Sugai T, Shinomura Y, Nakase H, Suzuki H. Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors. Oncol Lett 14: 5703-5710, 2017. |
| 21. |
Itabashi T, Emori M, Terashima Y, Hasegawa T, Shimizu J, Nagoya S, Yamashita T. Hemangioma of the rib showing a relatively high 18F-FDG uptake: a case report with a literature review. Acta Radiol Open 6: 1-5, 2017. |
| 22. |
Magara K, Takasawa A, Osanai M, Ota M, Tagami Y, Ono Y, Takasawa K, Murata M, Hirohashi Y, Miyajima M, Yamada G, Hasegawa T, Sawada N. Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma. Cancer Sci 108: 2306-2314, 2017. |
| 23. |
Jitsukawa S, Kamekura R, Kawata K, Ito F, Sato A, Matsumiya H, Nagaya T, Yamashita K, Kubo T, Kikuchi T, Sato N, Hasegawa T, Kiyonari H, Mukumoto Y, Takano KI, Himi T, Ichimiya S. Loss of sorting nexin 5 stabilizes internalized growth factor receptors to promote thyroid cancer progression. J Pathol 243: 342-353, 2017. |
| 24. |
Kato T, Ichihara S, Gotoda H, Muraoka S, Kubo T, Sugita S, Hasegawa T. Imprint cytology of clear cell sarcoma-like tumor of the gastrointestinal tract in the small intestine: A case report. Diagn Cytopathol 45: 1137-1141, 2017. |
| 25. |
Yokoyama R, Mikami T, Noshiro S, Miyata K, Toyama K, Komatsu K, Kikuchi N, Hasegawa T, Mikuni N. [Bone Flap Resorption after Cranioplasty in Pediatric Patients:Report of 2 Cases]. No Shinkei Geka 45: 47-52, 2017. |
| 26. |
Takasawa K, Takasawa A, Osanai M, Aoyama T, Ono Y, Kono T, Hirohashi Y, Murata M, Sawada N. Claudin-18 coupled with EGFR/ERK signaling contributes to the malignant potentials of bile duct cancer. Cancer Lett 403: 66-73, 2017. |
| 27. |
Aoki H, Yamamoto E, Takasawa A, Niinuma T, Yamano HO, Harada T, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Tanaka Y, Yoshida Y, Aoyama T, Eizuka M, Yorozu A, Kitajima H, Kai M, Sawada N, Sugai T, Nakase H, Suzuki H. Epigenetic silencing of SMOC1 in traditional serrated adenoma and colorectal cancer. Oncotarget 9: 4707-4721, 2017. |
| 28. |
瀬川惠子, 杉田真太朗, 菅原太郎, 伊藤夢美香, 菊地謙成, 平野博嗣, 守田玲菜, 中村裕之, 長谷川匡. 陰茎亀頭部に発生したsolitary circumscribed neuromaの1例. 診断病理 2017年. 34: 24-28. |
| 29. |
菅原太郎, 杉田真太朗, 平野博嗣, 藤田裕美, 瀬川惠子, 伊藤夢美香, 菊地謙成, 久保輝文, 田中綾一, 長谷川匡. PEComa様形態を示した卵巣硬化性間質性腫瘍の1例. 診断病理 2017年. 34: 29-33. |
| 30. |
青木貴徳, 鈴木茂貴, 石井大介, 稲葉聡, 矢吹英彦, 杉田真太朗, 長谷川匡. 肺原発滑膜肉腫の1例. 日本臨床外科学会雑誌 2017年. 78: 285-290. |
| 31. |
池田毅, 平岡美紀, 稲富周一郎, 舟橋謙二, 山下建, 杉田真太朗, 大黒浩. 両側涙嚢部に涙石を生じたシェーグレン症候群の2例. 臨床眼科 2017年. 71: pp593-598. |
| 32. |
岩田昌史, 川端紀子, 長谷川匡, 杉田真太朗. CD34陽性であった軟部神経周膜腫の1例. 臨床皮膚科 2017年. 71: 697-700. |
| 33. |
黒川 晶子, 玉手雅人, 長尾沙智子, 染谷真行, 郷久晴朗, 寺本瑞絵, 杉田真太朗, 田中綾, 岩崎雅宏, 岡村直樹, 齋藤豪. 初期子宮体癌の合併が診断しえたポリープ状異型腺筋腫の1例. 産科と婦人科 2017年. 84: 495 -498. |
| 34. |
藤田裕美. 【腎生検・病理診断-臨床と病理の架け橋】(第2章)臨床医が知っておくべき腎生検標本の作製と観察の実際 蛍光抗体法の標本の作製と観察 凍結ブロックの作製、切片作製のポイント（解説/特集）. 腎と透析 2017年. 82: 85-90. |
| 35. |
山口裕, 藤田裕美. 尿細管間質性腎炎. 腎生検病理アトラス 改訂版：東京医学社；2017年. pp290-295. |
| 36. |
横山林太郎, 三上毅, 能代将平, 宮田圭, 外山賢太郎, 小松克也, 菊地謙成, 長谷川匡, 三國信啓. 小児頭蓋形成術後の骨弁吸収 2症例の経験より. Neurological Surgery 2017年. 44: 857-861. |
| 37. |
程塚直人, 根元勺, 柳雅人, 長谷川匡, 近藤幸尋. 精索原発脱分化型脂肪肉腫の1例. 泌尿紀要 2017年. 63: 251-254. |
| 38. |
東恭悟（分担執筆）. 病理検査技術教本（JAMT技術標本シリーズ）. 丸善出版. 東京. 2017年. |
| 39. |
小山奈緒美, 山直也, 小野寺麻希, 小野寺耕一, 畠中正光, 山本元久, 志谷真啓, 杉田真太朗. 今月の症例 IgG4関連硬化性胆管炎(解説). 臨床放射線 2017年. 62: 1111-1114. |
| 40. |
小野寺耕一, 山直也, 小野寺麻希, 小山奈緒美, 畠中正光, 山下建, 鰐渕昌彦, 瀬川惠子. 今月の症例 デスモイド型線維腫症. 臨床放射線 2017年. 62: 1719-1722. |
| 41. |
江森誠人, 塚原智英, 杉田真太朗, 園田智子, 村橋靖崇, 清水淳也, 水島衣美, 相馬有, 佐々木幹人, 加谷光規, 名越智, 長谷川匡, 和田卓郎, 山下敏彦. CD109は粘液線維肉腫の予後予測因子である. 北海道整形災害外科学会雑誌 2017年. 59: 6-10. |
| 42. |
日榮良介, 平岡美紀, 青木悠, 渡部恵, 中島樹, 杉田真太朗, 大黒浩. 健常成人にみられた眼窩蜂窩織炎と眼内炎の同時発症例. 臨床眼科 2017年. 71: 1873-1879. |
|
|
 |
